Petmed Express INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SilverCape Investments Limited has submitted a revised non-binding proposal to acquire PetMed Express, Inc. for $3.00 per share in cash, representing a 70% premium over the recent closing price, citing the company's deteriorating financial condition and governance issues.
NASDAQ
Diveroli Investment Group LLC and Kingbird Ventures LLC have disclosed a 1.83% beneficial ownership stake in PetMed Express, Inc., signaling potential future influence.
NASDAQ
SilverCape Investments Limited has submitted a non-binding proposal to acquire all outstanding shares of PetMed Express Inc. for $4.00 per share in cash, aiming to take the company private.
NASDAQ
SCHEDULE 13D: Activist Investor SilverCape Investments Discloses 11.1% Stake in PetMed Express, Seeks Strategic Dialogue
SilverCape Investments Limited and its managing director Peter Kennedy have disclosed an 11.1% beneficial ownership stake in PetMed Express, Inc., signaling intent to engage with management on strategic decision-making and financial performance.